Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Young breast cancer patients share views on fertility risks in new survey

NCT ID NCT00062400

Knowledge-focused Sponsor: European Organisation for Research and Treatment of Cancer - EORTC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study surveyed 385 women aged 35 or younger with early-stage breast cancer to learn their attitudes about the risk of infertility from adjuvant therapy. The goal was to understand how concerns about having children might influence their treatment choices. The results could help doctors better support young patients in making informed decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this survey could help doctors better understand how young women weigh fertility risks when choosing breast cancer treatment, leading to more personalized care.
What could go wrong
This is a completed survey study, not a treatment trial. It gathered opinions but does not test any therapy or change outcomes directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 385 people

The number the study aims to enrol. It can still change while the study runs.

Start date

May 2003

Finished

Jun 2008

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed prior or current diagnosis of breast cancer * Stage I or II * No relapsed disease * No evidence of infertility * Regular menses or regular hormonal contraception use for the past 3 months * Hormonal status: * Not specified PATIENT CHARACTERISTICS: Age * 35 and under at diagnosis Sex * Female Menopausal status * Premenopausal Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * No psychological, familial, sociological, or geographical condition that would preclude study compliance PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * Not specified Endocrine therapy * See Disease Characteristics Radiotherapy * Not specified Surgery * Not specified

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm infertility disorder physiological sexual disorder Sexuality

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Psychosocial effects of cancer and its treatment Sexual dysfunction and infertility Sexuality and reproductive issues

Contacts and locations

Locations

  • Academisch Medisch Centrum at University of Amsterdam

    Amsterdam, 1105 AZ, Netherlands

  • Algemeen Ziekenhuis Sint-Augustinus

    Wilrijk, 2610, Belgium

  • American University of Beirut Medical Center

    Beirut, 113-6044, Lebanon

  • Arnhems Radiotherapeutisch Instituut

    Arnhem, 6815 AD, Netherlands

  • Azienda Istituti Ospitalieri

    Cremona, 26100, Italy

  • CHU Liege - Domaine Universitaire du Sart Tilman

    Liège, B-4000, Belgium

  • Centre Hospitalier Etterbeek Ixelles

    Brussels, B-1050, Belgium

  • Centro di Riferimento Oncologico - Aviano

    Aviano, 33081, Italy

  • Clinica Alemana

    Santiago, 5951, Chile

  • European Institute of Oncology

    Milan, 20141, Italy

  • Groote Schuur Hospital

    Cape Town, 7925, South Africa

  • Hospital Militar

    Santiago, Chile

  • Inselspital Bern

    Bern, CH-3010, Switzerland

  • Institut Jules Bordet

    Brussels, 1000, Belgium

  • Institute of Oncology and Radiology of Serbia

    Belgrade, 11000, Serbia

  • Instituto Nacional de Enfermedades Neoplasicas

    Lima, 34, Peru

  • Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA

    Lisbon, 1099-023 Codex, Portugal

  • Instituto de Radiomedicina

    Santiago, 10, Chile

  • Kantonsspital - St. Gallen

    Sankt Gallen, CH-9007, Switzerland

  • Klinikum der J.W. Goethe Universitaet

    Frankfurt, D-60590, Germany

  • Marmara University Hospital

    Istanbul, 81190, Turkey (Türkiye)

  • Medical University of Gdansk

    Gdansk, 80-211, Poland

  • Ospedale Alessandro Manzoni

    Lecco, 23900, Italy

  • Ospedale Beata Vergine

    Mendrisio, CH-6850, Switzerland

  • Universitatsklinikum Heidelberg

    Heidelberg, 69115, Germany

  • University Hospital Rebro

    Zagreb, 41000, Croatia

  • Western Infirmary

    Glasgow, Scotland, G11 6NT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.